JMFC
DNA icon

J.M. Forbes & Co’s Ginkgo Bioworks DNA Stock Holding History

J.M. Forbes & Co’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.3M Sell
1,028,391
-12,050
-1% -$100K 0.53% 54
2025
Q4 		$8.65M Sell
1,040,441
-19,900
-2% -$214K 0.7% 42
2025
Q3 		$15.5M Sell
1,060,341
-16,900
-2% -$202K 1.28% 23
2025
Q2 		$12.1M Sell
1,077,241
-17,323
-2% -$134K 1.11% 31
2025
Q1 		$6.24M Buy
1,094,564
+392,832
+56% +$4M 0.6% 52
2024
Q4 		$6.89M Buy
701,732
+576,732
+461% +$4.94M 0.66% 47
2024
Q3 		$1.02M Buy
+125,000
New +$1.25M 0.1% 79

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

J.M. Forbes & Co's DNA Position: Q1 2026 in Review

J.M. Forbes & Co reduced its Ginkgo Bioworks (DNA) stake by 1.2% in Q1 2026, selling an estimated $100K and leaving 1,028,391 shares worth $6.3M. The position accounts for 0.53% of the portfolio, ranked #54.

J.M. Forbes & Co first reported a position in DNA in Q3 2024 and has held it in 7 quarters since. The position peaked at $15.5M in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • J.M. Forbes & Co held 1,028,391 shares of Ginkgo Bioworks worth $6.3M as of Q1 2026.
  • J.M. Forbes & Co sold 12,050 Ginkgo Bioworks shares in Q1 2026, an estimated $100K.
  • Ginkgo Bioworks made up 0.53% of J.M. Forbes & Co's portfolio in Q1 2026, its #54 holding.
  • J.M. Forbes & Co first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 7 quarters since.
  • J.M. Forbes & Co's Ginkgo Bioworks position peaked at $15.5M in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on J.M. Forbes & Co's 13F filing for Q1 2026, filed 16 Apr 2026.